Serial Gene Expression Profiling in the Intact Human Heart

Brian D. Lowes, Ronald Zolty, Wayne A. Minobe, Alastair D. Robertson, Sonia Leach, Lawrence Hunter, Michael R. Bristow

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: In chronic heart failure due to a dilated cardiomyopathy phenotype, the molecular bases for contractile dysfunction and chamber remodeling remain largely unidentified. Methods: To investigate the feasibility of measuring global gene expression serially in the intact failing human heart, we performed repeated messenger RNA (mRNA) expression profiling using RNA extracted from endomyocardial biopsy specimens and gene chip methodology in 8 subjects with idiopathic dilated cardiomyopathy. In patients treated with β-blocking agents or placebo, myocardial gene expression was measured in endomyocardial biopsy material and radionuclide ejection fraction was measured at baseline and after 4 to 12 months of treatment. Gene expression was measured for 12,625 gene sequences by using Affymetrix U95 gene chips and commercially available software. For 6 mRNAs, gene chip results were compared with measurements made by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Results: In an unfiltered composite analysis of changes in expression detected in the patients with high-signal intensity chips, 241 genes showed an increase and 331 genes a decrease in mRNA abundance. There was good agreement between changes measured by quantitative RT-PCR and those determined by gene chips. There was less variance between differences in phenotype in patients sampled serially as compared between subjects with similar phenotypes sampled at baseline. Conclusions: Serial gene expression profiling with association to phenotypic change is feasible in the intact human heart and may offer advantages to cross-sectional expression profiling. This study suggests that the intact failing remodeled human heart is in an activated state of gene expression, with a large net reduction in gene expression occurring as phenotypic improvement occurs.

Original languageEnglish (US)
Pages (from-to)579-588
Number of pages10
JournalJournal of Heart and Lung Transplantation
Volume25
Issue number5
DOIs
StatePublished - May 1 2006

Fingerprint

Gene Expression Profiling
Oligonucleotide Array Sequence Analysis
Gene Expression
Dilated Cardiomyopathy
Reverse Transcriptase Polymerase Chain Reaction
Phenotype
Messenger RNA
Biopsy
Radioisotopes
Genes
Software
Heart Failure
Placebos
RNA

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this

Lowes, B. D., Zolty, R., Minobe, W. A., Robertson, A. D., Leach, S., Hunter, L., & Bristow, M. R. (2006). Serial Gene Expression Profiling in the Intact Human Heart. Journal of Heart and Lung Transplantation, 25(5), 579-588. https://doi.org/10.1016/j.healun.2006.01.006

Serial Gene Expression Profiling in the Intact Human Heart. / Lowes, Brian D.; Zolty, Ronald; Minobe, Wayne A.; Robertson, Alastair D.; Leach, Sonia; Hunter, Lawrence; Bristow, Michael R.

In: Journal of Heart and Lung Transplantation, Vol. 25, No. 5, 01.05.2006, p. 579-588.

Research output: Contribution to journalArticle

Lowes, BD, Zolty, R, Minobe, WA, Robertson, AD, Leach, S, Hunter, L & Bristow, MR 2006, 'Serial Gene Expression Profiling in the Intact Human Heart', Journal of Heart and Lung Transplantation, vol. 25, no. 5, pp. 579-588. https://doi.org/10.1016/j.healun.2006.01.006
Lowes, Brian D. ; Zolty, Ronald ; Minobe, Wayne A. ; Robertson, Alastair D. ; Leach, Sonia ; Hunter, Lawrence ; Bristow, Michael R. / Serial Gene Expression Profiling in the Intact Human Heart. In: Journal of Heart and Lung Transplantation. 2006 ; Vol. 25, No. 5. pp. 579-588.
@article{3f8114539357429cb9ec3ec8a4972bba,
title = "Serial Gene Expression Profiling in the Intact Human Heart",
abstract = "Background: In chronic heart failure due to a dilated cardiomyopathy phenotype, the molecular bases for contractile dysfunction and chamber remodeling remain largely unidentified. Methods: To investigate the feasibility of measuring global gene expression serially in the intact failing human heart, we performed repeated messenger RNA (mRNA) expression profiling using RNA extracted from endomyocardial biopsy specimens and gene chip methodology in 8 subjects with idiopathic dilated cardiomyopathy. In patients treated with β-blocking agents or placebo, myocardial gene expression was measured in endomyocardial biopsy material and radionuclide ejection fraction was measured at baseline and after 4 to 12 months of treatment. Gene expression was measured for 12,625 gene sequences by using Affymetrix U95 gene chips and commercially available software. For 6 mRNAs, gene chip results were compared with measurements made by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Results: In an unfiltered composite analysis of changes in expression detected in the patients with high-signal intensity chips, 241 genes showed an increase and 331 genes a decrease in mRNA abundance. There was good agreement between changes measured by quantitative RT-PCR and those determined by gene chips. There was less variance between differences in phenotype in patients sampled serially as compared between subjects with similar phenotypes sampled at baseline. Conclusions: Serial gene expression profiling with association to phenotypic change is feasible in the intact human heart and may offer advantages to cross-sectional expression profiling. This study suggests that the intact failing remodeled human heart is in an activated state of gene expression, with a large net reduction in gene expression occurring as phenotypic improvement occurs.",
author = "Lowes, {Brian D.} and Ronald Zolty and Minobe, {Wayne A.} and Robertson, {Alastair D.} and Sonia Leach and Lawrence Hunter and Bristow, {Michael R.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.healun.2006.01.006",
language = "English (US)",
volume = "25",
pages = "579--588",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Serial Gene Expression Profiling in the Intact Human Heart

AU - Lowes, Brian D.

AU - Zolty, Ronald

AU - Minobe, Wayne A.

AU - Robertson, Alastair D.

AU - Leach, Sonia

AU - Hunter, Lawrence

AU - Bristow, Michael R.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Background: In chronic heart failure due to a dilated cardiomyopathy phenotype, the molecular bases for contractile dysfunction and chamber remodeling remain largely unidentified. Methods: To investigate the feasibility of measuring global gene expression serially in the intact failing human heart, we performed repeated messenger RNA (mRNA) expression profiling using RNA extracted from endomyocardial biopsy specimens and gene chip methodology in 8 subjects with idiopathic dilated cardiomyopathy. In patients treated with β-blocking agents or placebo, myocardial gene expression was measured in endomyocardial biopsy material and radionuclide ejection fraction was measured at baseline and after 4 to 12 months of treatment. Gene expression was measured for 12,625 gene sequences by using Affymetrix U95 gene chips and commercially available software. For 6 mRNAs, gene chip results were compared with measurements made by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Results: In an unfiltered composite analysis of changes in expression detected in the patients with high-signal intensity chips, 241 genes showed an increase and 331 genes a decrease in mRNA abundance. There was good agreement between changes measured by quantitative RT-PCR and those determined by gene chips. There was less variance between differences in phenotype in patients sampled serially as compared between subjects with similar phenotypes sampled at baseline. Conclusions: Serial gene expression profiling with association to phenotypic change is feasible in the intact human heart and may offer advantages to cross-sectional expression profiling. This study suggests that the intact failing remodeled human heart is in an activated state of gene expression, with a large net reduction in gene expression occurring as phenotypic improvement occurs.

AB - Background: In chronic heart failure due to a dilated cardiomyopathy phenotype, the molecular bases for contractile dysfunction and chamber remodeling remain largely unidentified. Methods: To investigate the feasibility of measuring global gene expression serially in the intact failing human heart, we performed repeated messenger RNA (mRNA) expression profiling using RNA extracted from endomyocardial biopsy specimens and gene chip methodology in 8 subjects with idiopathic dilated cardiomyopathy. In patients treated with β-blocking agents or placebo, myocardial gene expression was measured in endomyocardial biopsy material and radionuclide ejection fraction was measured at baseline and after 4 to 12 months of treatment. Gene expression was measured for 12,625 gene sequences by using Affymetrix U95 gene chips and commercially available software. For 6 mRNAs, gene chip results were compared with measurements made by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Results: In an unfiltered composite analysis of changes in expression detected in the patients with high-signal intensity chips, 241 genes showed an increase and 331 genes a decrease in mRNA abundance. There was good agreement between changes measured by quantitative RT-PCR and those determined by gene chips. There was less variance between differences in phenotype in patients sampled serially as compared between subjects with similar phenotypes sampled at baseline. Conclusions: Serial gene expression profiling with association to phenotypic change is feasible in the intact human heart and may offer advantages to cross-sectional expression profiling. This study suggests that the intact failing remodeled human heart is in an activated state of gene expression, with a large net reduction in gene expression occurring as phenotypic improvement occurs.

UR - http://www.scopus.com/inward/record.url?scp=33646149396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646149396&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2006.01.006

DO - 10.1016/j.healun.2006.01.006

M3 - Article

C2 - 16678038

AN - SCOPUS:33646149396

VL - 25

SP - 579

EP - 588

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 5

ER -